MB, Levis & Associates’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8K Hold
478
﹤0.01% 172
2026
Q1
$10.8K Hold
478
﹤0.01% 164
2025
Q4
$11.4K Hold
478
﹤0.01% 161
2025
Q3
$12.6K Hold
478
0.01% 156
2025
Q2
$13.7K Hold
478
0.01% 182
2025
Q1
$11.9K Hold
478
0.01% 183
2024
Q4
$10.8K Hold
478
0.01% 183
2024
Q3
$10.2K Hold
478
0.01% 193
2024
Q2
$9.13K Hold
478
﹤0.01% 197
2024
Q1
$9.22K Hold
478
﹤0.01% 192
2023
Q4
$9.96K Hold
478
0.01% 185
2023
Q3
$10.3K Hold
478
0.01% 192
2023
Q2
$11.4K Hold
478
0.01% 189
2023
Q1
$10.2K Hold
478
0.01% 197
2022
Q4
$7.81K Buy
+478
New +$7.09K 0.01% 192

Other funds holding FMS

MB, Levis & Associates's FMS Position: Q2 2026 in Review

MB, Levis & Associates held its Fresenius Medical Care (FMS) position steady in Q2 2026 at 478 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #172.

MB, Levis & Associates first reported a position in FMS in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.7K in Q2 2025. 235 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • MB, Levis & Associates held 478 shares of Fresenius Medical Care worth $10.8K as of Q2 2026.
  • MB, Levis & Associates left its Fresenius Medical Care share count unchanged in Q2 2026.
  • Fresenius Medical Care made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #172 holding.
  • MB, Levis & Associates first reported a position in Fresenius Medical Care in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's Fresenius Medical Care position peaked at $13.7K in Q2 2025.
  • 235 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.